High dosage of aripiprazole-induced dysphagia
Authors:
- 3 May 2011
- journal article
- case report
- Published by Wiley in International Journal of Eating Disorders
- Vol. 45 (2) , 305-306
Abstract
Dysphagia as a main manifestation of extrapyramidal symptoms is an uncommon adverse effect of second-generation antipsychotics. We present a 54-year-old drug-naïve patient with schizophrenia, who developed dysphagia with aripiprazole 30 mg daily treatment. This is the first case report on aripiprazole-induced dysphagia. We discuss the risk factors that led to dysphagia in this case. Aripiprazole-induced dysphagia is rare, and it is important to be aware that it does occur with high-dosage treatment.Keywords
This publication has 13 references indexed in Scilit:
- Quetiapine-associated dysphagiaThe World Journal of Biological Psychiatry, 2009
- Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic reviewPsychological Medicine, 2008
- Quetiapine-Related DysphagiaPsychosomatics, 2008
- Extrapyramidal Syndrome Presenting as Dysphagia: A Case ReportAmerican Journal of Hospice and Palliative Medicine®, 2008
- Neuroleptic-Induced Dysphagia: Case Report and Literature ReviewDysphagia, 2006
- Aripiprazole, a novel antipsychotic agent: Dopamine D2 receptor partial agonistThe Journal of Medical Investigation, 2005
- Dysphagia Associated with Risperidone TherapyDysphagia, 2003
- Neuroleptic-Induced DysphagiaDysphagia, 1997
- Drug-Induced Parkinsonism Associated with Dysphagia and Aspiration: A Brief ReportJournal of Geriatric Psychiatry and Neurology, 1996
- Swallowing and speech production in Parkinson's diseaseAnnals of Neurology, 1986